Stem-cell funding still mired in courts
By Steve Johnson,
San Jose Mercury News
| 11. 30. 2005
JUDGE RULES SUITS ON PROPOSITION 71 CAN GO TO TRIAL
By Steve Johnson
Mercury News
A judge Tuesday denied a motion to dismiss two lawsuits challenging the legality of California's year-old $3 billion stem-cell institute, making it likely public funding for the institute will continue to be blocked well into next year.
Alameda County Superior Court Judge Bonnie Sabraw also denied motions by the plaintiffs, who had asked her to declare the stem-cell program unconstitutional.
Sabraw ordered the parties back to court Tuesday to set a trial date, noting that she planned to ``proceed to trial promptly.'' Both sides in the case said it's possible a trial might not begin until spring. Whoever loses at that point is expected to file an appeal, dragging the case out even longer.
Even so, Robert Klein, who chairs the California Institute for Regenerative Medicine, said he was happy with the judge's ruling because it found no immediate reason to declare the stem-cell program unconstitutional.
``We would have loved to have a home run,'' by having the suits dismissed, Klein said. ``But boy, this...
Related Articles
By Rob Stein, NPR | 09.30.2025
Scientists have created human eggs containing genes from adult skin cells, a step that someday could help women who are infertile or gay couples have babies with their own genes but would also raise difficult ethical, social and legal issues...
By Aleks Krotoski, The Guardian | 09.28.2025
Imagine you’re the leader of one of the most powerful nations in the world. You have everything you could want at your disposal: power, influence, money. But, the problem is, your time at the top is fleeting. I’m not...
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...
